# Boston Scientific Corporation (BSX) — Q4-2013 Earnings Results

**Report date:** 2014-02-04 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q4-2013

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Down 1.23%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.21 | N/A | +9.38% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about the company's direction. They acknowledged market challenges but emphasized their commitment to innovation.

**Key quotes:**

> Management highlighted the strong performance in key product segments.

> They noted ongoing challenges in the market but expressed confidence in future growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 1.23%, likely due to the absence of revenue details and forward guidance, which may leave investors uncertain about future performance. The cautious tone from management suggests they are aware of market challenges ahead.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q4-2013_